Skip to main content

EMPLICITI

NDC 0003-4522 · E.R. Squibb & Sons, L.L.C.

Generic nameelotuzumab
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAVENOUS
Active ingredient(s)ELOTUZUMAB
Strength400 mg/1
Pharmacologic classAntibodies, Monoclonal [CS], SLAMF7-directed Antibody Interactions [MoA], SLAMF7-directed Immunostimulatory Antibody [EPC]
Marketing categoryBLA

Packages

0003-4522-11 — 1 VIAL, SINGLE-USE in 1 CARTON (0003-4522-11) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE

Billed under HCPCS

J9176 — Injection, elotuzumab, 1 mg Medicare Part B payment limit (ASP + 6%): $8.19

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0003-2291 — elotuzumab

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources